Rodrigo Rivera

Prior to joining Kirkland, Rodrigo was involved in the following representative matters:

• ARCHIMED:
  • in its acquisition of ARK Diagnostics from Soulbrain Holdings.
  • and its portfolio company NAMSA in its strategic acquisition of WuXi AppTec’s U.S. medical device testing operations.
• Court Square Capital Partners:
  • and Kodiak Building Partners on Kodiak’s sale to QXO, Inc. for approximately $2.25 billion.
  • in its acquisition of CallTower, a global leader in enterprise-class cloud communications and collaboration solutions.
  • and its affiliates in connection with its acquisition of Chauvet & Sons, LLC, a leading developer, manufacturer and marketer of branded entertainment and architectural lighting products, control systems, power distribution products, and related equipment, from its former sponsor, Cortec Group Management Services, LLC.
• CVC Capital Partners, as the lead investor in a consortium that sponsored the combination of Worldwide Express, LLC and GlobalTranz Enterprises, LLC to create an industry leader with unique technology capabilities and market-leading solutions for the freight and parcel markets. Other consortium members include GlobalTranz's prior lead investors, Providence Equity Partners and PSG, while prior Worldwide Express lead investor, Ridgemont Equity Partners, also retained a significant stake in the combined entity.
• Graham Partners:
  • in its acquisition of Smithstown, a medical device manufacturer specializing in highly engineered, machined components and sub-assemblies for orthopedic, endoscopic, vascular and neurological surgical applications.
  • and its portfolio company, Barcoding Holdings, LLC, in its take-private acquisition of DecisionPoint Systems, Inc., a leading mobility-first enterprise services and solutions company and a leading provider of retail in-store solutions and services centered on Point-of-Sale systems, and subsequent add-ons of Imprint and Acuity.
  • and its affiliates in connection with its purchase of Rhythmlink, a designer and manufacturer of single-use brain health and neurodiagnostic solutions.
  • in its acquisition of BrightSign, a provider of purpose-built media players and cloud-based networking and systems software for the worldwide digital signage market.
• Morgan Stanley Capital Partners:
  • in connection with the sale of its portfolio company, Clarity Software Solutions, to mPulse, a provider of Health Experience and Insights technology.
  • and its portfolio company US HealthConnect in connection with the acquisition of Bryn Mawr Communications and Evolve Medical Education, leaders in healthcare information and education.
• One Equity Partners in connection with its acquisition of Liquid Web, LLC from its former parent company Madison Dearborn Capital Partners, and subsequent add-on acquisition of XBT.
• Select Medical Holdings Corporation, a leading operator of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers:
  • in its proposed take-private transaction by a consortium led by Robert A. Ortenzio, Martin F. Jackson and Welsh, Carson, Anderson & Stowe from its founder.
  • and Concentra Group Holdings Parent, Inc., a wholly owned subsidiary of Select Medical, in connection with Concentra’s IPO.
• US Ecology in its sale to Republic Services.